SM8T:F:F-Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 658.1

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.09 (-0.31%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.21 (-0.41%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.28 (+0.05%)

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.06 (-0.40%)

USD 63.18B
VUSA:F Vanguard Funds Public Limited ..

-0.61 (-0.56%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.98 (-0.90%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.80 (-0.33%)

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

+0.06 (+0.77%)

USD 43.12B
0ZC:F Zscaler Inc

+2.50 (+1.39%)

USD 37.92B

ETFs Containing SM8T:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.70% 56% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.70% 55% F 51% F
Trailing 12 Months  
Capital Gain 19.42% 75% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.42% 71% C- 60% D-
Trailing 5 Years  
Capital Gain 47.54% 75% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.54% 75% C 54% F
Average Annual (5 Year Horizon)  
Capital Gain 11.59% 74% C 68% D+
Dividend Return 11.59% 72% C 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.70% 53% F 85% B
Risk Adjusted Return 91.27% 87% B+ 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike